The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final report: A phase I trial of BYL719 in combination with gemcitabine and nab-paclitaxel in locally advanced and metastatic pancreatic cancer.
 
Heloisa P. Soares
Consulting or Advisory Role - Cornerstone Pharmaceuticals; Ipsen
Speakers' Bureau - Celgene; Novartis
 
Taymeyah E. Al-Toubah
No Relationships to Disclose
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Lilly; Taiho Pharmaceutical
Research Funding - Bayer; Eisai; Novartis
 
Jongphil Kim
No Relationships to Disclose
 
Neron K Lewis
No Relationships to Disclose
 
Amit Mahipal
Research Funding - Astellas Scientific and Medical Affairs Inc (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)